$147.47
7.375.26%
At close: -
$140.58
-6.89-4.67%
After Hours: Jan 28, 9:29 AM EDT
Comments
Loading...
AstraZeneca Analyst Ratings and Price Targets | OTC:AZNCF | Benzinga
AstraZeneca Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for AstraZeneca Corp from these most-recent analyst ratings.
Analyst Ratings for AstraZeneca
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for AstraZeneca (AZNCF) stock?
There is no price target for AstraZeneca
What is the most recent analyst rating for AstraZeneca (AZNCF)?
There is no analyst for AstraZeneca
When was the last upgrade for AstraZeneca (AZNCF)?
There is no last upgrade for AstraZeneca
When was the last downgrade for AstraZeneca (AZNCF)?
There is no last downgrade for AstraZeneca.
When is the next analyst rating going to be posted or updated for AstraZeneca (AZNCF)?
There is no next analyst rating for AstraZeneca.
Is the Analyst Rating AstraZeneca (AZNCF) correct?
There is no next analyst rating for AstraZeneca.
Browse analyst ratings and price targets on all stocks.